secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2026-09-22T13:06:43+00:00
Accession:  0001493152-26-043659
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid advances EsoGuard/EsoCheck Medicare coding, payment backing from CMS, AMA, CDC
--------------------------------------------------------------------------------

- CMS Advisory Panel recommends keeping EsoGuard's original gapfill payment basis (PLA code 0114U); final determinations due in November.
- AMA CPT Editorial Panel approves new Category III CPT code for non-endoscopic esophageal cell collection with EsoCheck.
- CDC/NCHS ICD-10 committee favorably receives proposed code R85.83 for positive EsoGuard results.
- Texas lab will begin submitting Medicare claims under 0114U this month; California lab to follow once revised LCD is effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226043659/0001493152-26-043659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315226043659/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer